Article
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity
2 Jun 2022
Abstract excerpt
Abstract Background Chronic graft-versus-host disease (cGVHD) remains a major complication during the late phase of allogeneic hematopoietic stem cell transplantation (allo-HSCT). IL-39, a newly described pro-inflammatory cytokine belonging to the IL-12 family, plays a role in lupus development. Recently, IL-39 has been identified as a pathogenic factor in acute GVHD (aGVHD). However, the role of IL-39 in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
